» Articles » PMID: 38055924

Dietary Risk Factors for Monoclonal Gammopathy of Undetermined Significance in a Racially Diverse Population

Overview
Journal Blood Adv
Specialty Hematology
Date 2023 Dec 6
PMID 38055924
Authors
Affiliations
Soon will be listed here.
Abstract

Monoclonal gammopathy of undetermined significance (MGUS), a precursor of multiple myeloma, is associated with shorter lifespan and cardiac, renal, neurologic, and immune-related comorbidities. There is little known about modifiable risk factors for this condition. To determine whether the risk of MGUS is associated with dietary factors in a racially diverse population, we conducted a US population-based case-control study from the National Health and Nutrition Examination Survey (1988-2004), which included 373 individuals with MGUS and 1406 matched controls. Diet was characterized by one 24-hour dietary recall, with gram intake of individual foods and beverages aggregated into groups. Unconditional multivariable logistic regressions were used to model associations between intake of several food groups and MGUS, with odds ratios (ORs) and 95% confidence intervals (CIs) reported for the highest relative to the lowest quantile of intake. Daily gram intake of several food and beverage groups were significantly associated with MGUS. MGUS was inversely associated with whole-grain bread, oats, and rice (OR, 0.70; 95% CI, 0.48-1.00; P < .05), fruits (excluding juice) and vegetables (OR, 0.69; 95% CI, 0.52-0.93; P = .02), vegetables (OR, 0.75; 95% CI, 0.56-0.99; P < .05), tomatoes (OR, 0.72; 95% CI, 0.51-1.00; P < .05), and cruciferous vegetables (OR, 0.44; 95% CI, 0.26-0.74; P < .01). Direct associations were observed for sugar-sweetened beverages (OR, 1.34; 95% CI, 1.00-1.78; P < .05), sugar-sweetened soft drinks (OR, 1.41; 95% CI, 1.01-1.96; P = .04), and artificially sweetened soft drinks (OR, 1.55; 95% CI, 1.04-2.33; P = .03). Our study shows that diet is potentially a modifiable risk factor for MGUS.

Citing Articles

Prevalence of metabolic comorbidities and viral co-infections in monoclonal gammopathy: a retrospective analysis.

Muradashvili T, Yu M, Browning S, Bar N, Gorshein E, Parker T Leukemia. 2024; 38(10):2281-2283.

PMID: 39164408 DOI: 10.1038/s41375-024-02380-x.


The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple Myeloma.

Malamos P, Papanikolaou C, Gavriatopoulou M, Dimopoulos M, Terpos E, Souliotis V Int J Mol Sci. 2024; 25(13).

PMID: 39000097 PMC: 11241508. DOI: 10.3390/ijms25136991.

References
1.
Shah U, Rognvaldsson S, Derkach A, Bjorkholm M, Turesson I, David Y . Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls. Haematologica. 2021; 107(1):284-286. PMC: 8719074. DOI: 10.3324/haematol.2021.278772. View

2.
Tabung F, Smith-Warner S, Chavarro J, Wu K, Fuchs C, Hu F . Development and Validation of an Empirical Dietary Inflammatory Index. J Nutr. 2016; 146(8):1560-70. PMC: 4958288. DOI: 10.3945/jn.115.228718. View

3.
Aune D, Giovannucci E, Boffetta P, Fadnes L, Keum N, Norat T . Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies. Int J Epidemiol. 2017; 46(3):1029-1056. PMC: 5837313. DOI: 10.1093/ije/dyw319. View

4.
Sprynski A, Hose D, Caillot L, Reme T, Shaughnessy Jr J, Barlogie B . The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor. Blood. 2009; 113(19):4614-26. PMC: 2691749. DOI: 10.1182/blood-2008-07-170464. View

5.
Dalamaga M, Diakopoulos K, Mantzoros C . The role of adiponectin in cancer: a review of current evidence. Endocr Rev. 2012; 33(4):547-94. PMC: 3410224. DOI: 10.1210/er.2011-1015. View